Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer

NCT02546531 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02546531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02546531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
February 3, 2016
Completion date
January 11, 2021
Enrollment
43 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors, pancreatic cancer, solid tumors